As More DLL3 Bispecifics Advance, Doctors Are Adjusting To CRS, ICANS

BiTEs Bring New Side Effects To Solid Tumor Setting

 
• By Mandy Jackson
  
Health care and medical technology services concept. Medical worker using data virtual with health care icons, medical technology background, health insurance business.
Bispecific T-cell engagers require new safety protocols in treating solid tumors • Source: Shutterstock

More from Clinical Trials

More from R&D